1927 (1927) Fair Value & Analysis

Consumer Defensive · Market cap HK$173M

1 1927 1927 · HK

PriceHK$0.2180

Fair ValueHK$0.3000

Upside+37.6%

Quality65/100

Watch 1927 for free — get notified when fair value or trend changes. Watch for free

Evidence: Medium Range HK$0.1500 – HK$0.4600

Fair value as of: Jul 2, 2026

From 14 valuation models · updated today

Share price −9.5% over the past month.

Price vs Fair Value (12 months)

12‑month range HK$0.1010 – HK$0.2550 · fair‑value band HK$0.1500 – HK$0.4600 · the HK$0.2180 price screens below the HK$0.3000 fair value. As of Jul 2, 2026.

✦ Which stocks are undervalued right now? Check free Discover now →

Analysis

1927 (1927) currently trades at HK$0.2180, while our model-based Fair Value estimate is HK$0.3000 — implying the stock looks roughly 37.6% undervalued today. We read business quality at 65/100 (solid quality), in the Consumer Defensive sector. Bull case: trading below our estimate, it may offer upside if the fundamentals hold. Bear case: a low price can be a value trap when quality is weak or the data is thin (evidence: medium) — always confirm before acting.

Over the trailing twelve months, 1927 generated revenue of HK$308M at a net margin of -2.5%. Revenue grew 9.1% year over year. It earns a return on equity of -1.9%. Net debt stands at HK$252M. Fundamentals as of Jul 2, 2026

Key figures & financial health

Revenue (TTM) HK$308M

Revenue growth (YoY) +9.1%

Net margin -2.5%

Return on equity -1.9%

Free cash flow HK$31.7M FY2025

Operating margin -3.7%

More key figures

EPS (TTM) HK$0.0200

EPS growth (YoY) -47.8%

Net debt HK$252M FY2025

Figures from reported company fundamentals (EODHD) · as of Jul 2, 2026. TTM = trailing twelve months.

Revenue & earnings trend

FY2021 – FY2025 · reported fiscal years

1927 reported revenue of HK$300M in FY2025 versus HK$410M in FY2021, a compound −7.5%/yr. Reported net income was −HK$7.4M in FY2025.

Revenue −7.5%/yr

FY21 HK$410M

FY22 HK$376M

FY23 HK$352M

FY24 HK$315M

FY25 HK$300M

Net income

FY21 HK$27.3M

FY22 HK$16.1M

FY23 HK$4.9M

FY24 −HK$3.6M

FY25 −HK$7.4M

Is 1927 fairly valued? → Check now

Similar stocks

6 more Confectioners stocks, each showing price versus our Fair Value estimate (as of Jul 2, 2026).

Stock	Price	Fair Value	vs Fair Value
Chocoladefabriken Lindt & Sprüngli AG LISN	CHF 94,300	CHF 8,228	-91%
MDLZ MDLZ	1,104 MXN	33.78 MXN	-97%
Mondelez International, Inc MDLZ34	R$165.92	R$98.18	-41%
The Hershey Company HSY	$176.61	$126.21	-29%
Barry Callebaut AG BARN	CHF 1,128	CHF 654.80	-42%
ORION Corp 271560	132,500 KRW	184,578 KRW	+39%

Explore undervalued stocks

More undervalued Consumer Defensive stocks →

All undervalued stocks Technology Financial Services Healthcare Consumer Cyclical Consumer Defensive Communication Services Industrials Energy Basic Materials Real Estate Utilities Deeply Undervalued Stocks Undervalued Blue-Chip Stocks Undervalued Small-Cap Stocks

Frequently asked questions

Is 1927 (1927) undervalued?

As of Jul 2, 2026, our model estimates a fair value of HK$0.3000 versus a price of HK$0.2180 — about +38% (undervalued). Model-based estimate, not financial advice.

What is the fair value of 1927?

Our model-based fair value for 1927 is HK$0.3000 (as of Jul 2, 2026), built from audited fundamentals. The current price is HK$0.2180.

What is the quality score of 1927?

1927 has a Quality Score of 65/100, measuring profitability, growth and balance-sheet strength from non-valuation factors.

What is the revenue of 1927 (1927)?

1927 reported trailing-twelve-month revenue of about HK$308M (latest available figure, as of Jul 2, 2026).

What is the net profit margin of 1927?

The net profit margin of 1927 is about -2.5%, meaning it is currently running at a net loss. Based on the latest reported figures.

How we calculate Fair Value

Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.

Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.